跳至主要内容
临床试验/NCT07328113
NCT07328113已完成不适用

Association Between Interleukin-6 and Thyroid Hormone Dysfunction in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Dr. Soetomo General Hospital2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2023年11月14日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
2
主要终点
Correlation between serum Interleukin-6 (IL-6) concentration and serum Thyroid-Stimulating Hormone (TSH) levels

研究概览

简要总结

Chronic kidney disease (CKD) is often associated with multiorgan complications, including thyroid hormone dysfunction. Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been proposed as a marker of inflammation that may contribute to these alterations. The main question it aims to answer is:

Is there an association between interleukin-6 and thyroid hormone dysfunction in patients with chronic kidney disease (CKD) Blood samples will be collected and analyzed from 65 patients who have undergone hemodialysis for at least 3 months.

详细描述

This cross-sectional observational study involves patients with CKD undergoing hemodialysis at Airlangga University Hospital. Data were collected based on their medical record and Blood test for IL-6. Linear regression analysis assessed the relationship between IL-6 levels and thyroid function parameters.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21 Years Old and above
  • Patients with ESRD who have undergone hemodialysis for ≥ 3 months and are in stable condition.
  • Patients are able to communicate and respond to questions appropriately
  • Patients are willing to participate in the study.

排除标准

  • ESRD patients undergoing hemodialysis who have been diagnosed with underlying thyroid disorders or thyroid malignancy.
  • Patients with a history of thyroid surgery or any intervention involving the thyroid gland.
  • Patients with a family history of thyroid disorders.
  • Patients taking medications that affect thyroid function or using antioxidant drugs.
  • Patients with infection or sepsis.

结局指标

主要结局

Correlation between serum Interleukin-6 (IL-6) concentration and serum Thyroid-Stimulating Hormone (TSH) levels

时间窗: At baseline, during routine hemodialysis visit (prior to any study-specific intervention)

Serum IL-6 (pg/mL) and TSH (µIU/mL) will be measured using standardized hospital laboratory immunoassay analyzers. The outcome is the correlation coefficient (Spearman r) between IL-6 and TSH.

次要结局

  • Correlation between serum IL-6 concentration and serum Total Triiodothyronine (T3) levels(At baseline, during routine hemodialysis visit (prior to any study-specific intervention))
  • Correlation between serum IL-6 concentration and serum Total Thyroxine (T4) levels(At baseline, during routine hemodialysis visit (prior to any study-specific intervention))
  • Correlation between serum IL-6 concentration and Free Triiodothyronine (fT3) levels(At baseline, during routine hemodialysis visit (prior to any study-specific intervention))
  • Correlation between serum IL-6 concentration and Free Thyroxine (fT4) levels(At baseline, during routine hemodialysis visit (prior to any study-specific intervention))

研究者

发起方
Dr. Soetomo General Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Interleukin-6 and Thyroid Dysfunction in... | 临床试验